Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Close correlation between CXCR4 and VEGF expression and frequent CXCR7 expression in rhabdomyosarcoma.

Miyoshi K, Kohashi K, Fushimi F, Yamamoto H, Kishimoto J, Taguchi T, Iwamoto Y, Oda Y.

Hum Pathol. 2014 Sep;45(9):1900-9. doi: 10.1016/j.humpath.2014.05.012. Epub 2014 Jun 12.

PMID:
25086956
[PubMed - indexed for MEDLINE]
2.

Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas.

Grymula K, Tarnowski M, Wysoczynski M, Drukala J, Barr FG, Ratajczak J, Kucia M, Ratajczak MZ.

Int J Cancer. 2010 Dec 1;127(11):2554-68. doi: 10.1002/ijc.25245.

PMID:
20162608
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.

Onisto M, Slongo ML, Gregnanin L, Gastaldi T, Carli M, Rosolen A.

Int J Oncol. 2005 Sep;27(3):791-8.

PMID:
16077930
[PubMed - indexed for MEDLINE]
4.

Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas.

Tarnowski M, Grymula K, Reca R, Jankowski K, Maksym R, Tarnowska J, Przybylski G, Barr FG, Kucia M, Ratajczak MZ.

Mol Cancer Res. 2010 Jan;8(1):1-14. doi: 10.1158/1541-7786.MCR-09-0259. Epub 2010 Jan 12.

PMID:
20068066
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.

Gee MF, Tsuchida R, Eichler-Jonsson C, Das B, Baruchel S, Malkin D.

Oncogene. 2005 Dec 1;24(54):8025-37.

PMID:
16116481
[PubMed - indexed for MEDLINE]
6.

C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancer.

Yates TJ, Knapp J, Gosalbez M, Lokeshwar SD, Gomez CS, Benitez A, Ekwenna OO, Young EE, Manoharan M, Lokeshwar VB.

Cancer. 2013 Jan 1;119(1):61-71. doi: 10.1002/cncr.27661. Epub 2012 Jun 26.

PMID:
22736438
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.

van Gaal JC, Roeffen MH, Flucke UE, van der Laak JA, van der Heijden G, de Bont ES, Suurmeijer AJ, Versleijen-Jonkers YM, van der Graaf WT.

Eur J Cancer. 2013 Nov;49(16):3462-70. doi: 10.1016/j.ejca.2013.06.022. Epub 2013 Jul 15.

PMID:
23867124
[PubMed - indexed for MEDLINE]
8.

Chemokine receptor CXCR4 expression is correlated with VEGF expression and poor survival in soft-tissue sarcoma.

Oda Y, Tateishi N, Matono H, Matsuura S, Yamamaoto H, Tamiya S, Yokoyama R, Matsuda S, Iwamoto Y, Tsuneyoshi M.

Int J Cancer. 2009 Apr 15;124(8):1852-9. doi: 10.1002/ijc.24128.

PMID:
19107931
[PubMed - indexed for MEDLINE]
9.

High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma.

Wang L, Chen W, Gao L, Yang Q, Liu B, Wu Z, Wang Y, Sun Y.

World J Surg Oncol. 2012 Oct 7;10:212. doi: 10.1186/1477-7819-10-212.

PMID:
23039915
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcoma.

Oda Y, Kohashi K, Yamamoto H, Tamiya S, Kohno K, Kuwano M, Iwamoto Y, Tajiri T, Taguchi T, Tsuneyoshi M.

Cancer Sci. 2008 Apr;99(4):726-32. doi: 10.1111/j.1349-7006.2008.00748.x.

PMID:
18377424
[PubMed - indexed for MEDLINE]
11.

Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.

Zibat A, Missiaglia E, Rosenberger A, Pritchard-Jones K, Shipley J, Hahn H, Fulda S.

Oncogene. 2010 Dec 2;29(48):6323-30. doi: 10.1038/onc.2010.368. Epub 2010 Sep 6.

PMID:
20818440
[PubMed - indexed for MEDLINE]
12.

Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer.

D'Alterio C, Consales C, Polimeno M, Franco R, Cindolo L, Portella L, Cioffi M, Calemma R, Marra L, Claudio L, Perdonà S, Pignata S, Facchini G, Cartenì G, Longo N, Pucci L, Ottaiano A, Costantini S, Castello G, Scala S.

Curr Cancer Drug Targets. 2010 Nov;10(7):772-81.

PMID:
20578990
[PubMed - indexed for MEDLINE]
13.

Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer.

Iwakiri S, Mino N, Takahashi T, Sonobe M, Nagai S, Okubo K, Wada H, Date H, Miyahara R.

Cancer. 2009 Jun 1;115(11):2580-93. doi: 10.1002/cncr.24281.

PMID:
19309748
[PubMed - indexed for MEDLINE]
Free Article
14.

Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis.

Gahan JC, Gosalbez M, Yates T, Young EE, Escudero DO, Chi A, Garcia-Roig M, Satyanarayana R, Soloway MS, Bird VG, Lokeshwar VB.

J Urol. 2012 Mar;187(3):827-33. doi: 10.1016/j.juro.2011.10.150. Epub 2012 Jan 15.

PMID:
22245330
[PubMed - indexed for MEDLINE]
15.

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.

Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, Nasti G, Barletta E, Facchini G, Daniele B, Di Blasi A, Napolitano M, Ieranò C, Calemma R, Leonardi E, Albino V, De Angelis V, Falanga M, Boccia V, Capuozzo M, Parisi V, Botti G, Castello G, Vincenzo Iaffaioli R, Scala S.

Clin Cancer Res. 2006 May 1;12(9):2795-803.

PMID:
16675573
[PubMed - indexed for MEDLINE]
Free Article
16.

Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.

Annavarapu SR, Cialfi S, Dominici C, Kokai GK, Uccini S, Ceccarelli S, McDowell HP, Helliwell TR.

Lab Invest. 2013 Oct;93(10):1090-9. doi: 10.1038/labinvest.2013.97. Epub 2013 Sep 2.

PMID:
23999248
[PubMed - indexed for MEDLINE]
Free Article
17.

Close correlation between CXCR4 and VEGF expression and their prognostic implications in nasopharyngeal carcinoma.

Segawa Y, Oda Y, Yamamoto H, Shiratsuchi H, Hirakawa N, Komune S, Tsuneyoshi M.

Oncol Rep. 2009 May;21(5):1197-202.

PMID:
19360294
[PubMed - indexed for MEDLINE]
18.

ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status.

Corao DA, Biegel JA, Coffin CM, Barr FG, Wainwright LM, Ernst LM, Choi JK, Zhang PJ, Pawel BR.

Pediatr Dev Pathol. 2009 Jul-Aug;12(4):275-83. doi: 10.2350/08-03-0434.1.

PMID:
18788887
[PubMed - indexed for MEDLINE]
19.

Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma.

Diomedi-Camassei F, McDowell HP, De Ioris MA, Uccini S, Altavista P, Raschellà G, Vitali R, Mannarino O, De Sio L, Cozzi DA, Donfrancesco A, Inserra A, Callea F, Dominici C.

Clin Cancer Res. 2008 Jul 1;14(13):4119-27. doi: 10.1158/1078-0432.CCR-07-4446.

PMID:
18593989
[PubMed - indexed for MEDLINE]
Free Article
20.

Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.

Heerema-McKenney A, Wijnaendts LC, Pulliam JF, Lopez-Terrada D, McKenney JK, Zhu S, Montgomery K, Mitchell J, Marinelli RJ, Hart AA, van de Rijn M, Linn SC.

Am J Surg Pathol. 2008 Oct;32(10):1513-22. doi: 10.1097/PAS.0b013e31817a909a.

PMID:
18708938
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk